These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18460741)

  • 1. Protein phosphatase and TRAIL receptor genes as new candidate tumor genes on chromosome 8p in prostate cancer.
    Hornstein M; Hoffmann MJ; Alexa A; Yamanaka M; Müller M; Jung V; Rahnenführer J; Schulz WA
    Cancer Genomics Proteomics; 2008; 5(2):123-36. PubMed ID: 18460741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic inactivation of TRAIL decoy receptors at 8p12-21.3 commonly deleted region confers sensitivity to Apo2L/trail-Cisplatin combination therapy in cervical cancer.
    Narayan G; Xie D; Ishdorj G; Scotto L; Mansukhani M; Pothuri B; Wright JD; Kaufmann AM; Schneider A; Arias-Pulido H; Murty VV
    Genes Chromosomes Cancer; 2016 Feb; 55(2):177-89. PubMed ID: 26542757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types.
    Shivapurkar N; Toyooka S; Toyooka KO; Reddy J; Miyajima K; Suzuki M; Shigematsu H; Takahashi T; Parikh G; Pass HI; Chaudhary PM; Gazdar AF
    Int J Cancer; 2004 May; 109(5):786-92. PubMed ID: 14999791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation.
    van Noesel MM; van Bezouw S; Salomons GS; Voûte PA; Pieters R; Baylin SB; Herman JG; Versteeg R
    Cancer Res; 2002 Apr; 62(7):2157-61. PubMed ID: 11929838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer.
    Cheng Y; Kim JW; Liu W; Dunn TA; Luo J; Loza MJ; Kim ST; Zheng SL; Xu J; Isaacs WB; Chang BL
    Prostate; 2009 Feb; 69(3):327-35. PubMed ID: 19035483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clustering of hypermethylated genes in neuroblastoma.
    van Noesel MM; van Bezouw S; Voûte PA; Herman JG; Pieters R; Versteeg R
    Genes Chromosomes Cancer; 2003 Nov; 38(3):226-33. PubMed ID: 14506696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of DNA methyltransferases on the epigenetic regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in malignant melanoma.
    Venza M; Visalli M; Catalano T; Fortunato C; Oteri R; Teti D; Venza I
    Biochem Biophys Res Commun; 2013 Nov; 441(4):743-50. PubMed ID: 24211571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
    Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
    Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells.
    Sanlioglu AD; Dirice E; Aydin C; Erin N; Koksoy S; Sanlioglu S
    BMC Cancer; 2005 May; 5():54. PubMed ID: 15916713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haploinsufficiency and reduced expression of genes localized to the 8p chromosomal region in human prostate tumors.
    Chaib H; MacDonald JW; Vessella RL; Washburn JG; Quinn JE; Odman A; Rubin MA; Macoska JA
    Genes Chromosomes Cancer; 2003 Jul; 37(3):306-13. PubMed ID: 12759929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes.
    Kagan J; Stein J; Babaian RJ; Joe YS; Pisters LL; Glassman AB; von Eschenbach AC; Troncoso P
    Oncogene; 1995 Nov; 11(10):2121-6. PubMed ID: 7478532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-specificity phosphatase 1 and serum/glucocorticoid-regulated kinase are downregulated in prostate cancer.
    Rauhala HE; Porkka KP; Tolonen TT; Martikainen PM; Tammela TL; Visakorpi T
    Int J Cancer; 2005 Dec; 117(5):738-45. PubMed ID: 15981206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DcR2 (TRAIL-R4) siRNA and adenovirus delivery of TRAIL (Ad5hTRAIL) break down in vitro tumorigenic potential of prostate carcinoma cells.
    Sanlioglu AD; Karacay B; Koksal IT; Griffith TS; Sanlioglu S
    Cancer Gene Ther; 2007 Dec; 14(12):976-84. PubMed ID: 17853923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation frequency of TNFRSF10C promoter in pancreatic cancer cell lines.
    Cai HH; Sun YM; Miao Y; Gao WT; Peng Q; Yao J; Zhao HL
    Hepatobiliary Pancreat Dis Int; 2011 Feb; 10(1):95-100. PubMed ID: 21269942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of chromosome arm 8p loci in prostate cancer: mapping by quantitative allelic imbalance.
    MacGrogan D; Levy A; Bostwick D; Wagner M; Wells D; Bookstein R
    Genes Chromosomes Cancer; 1994 Jul; 10(3):151-9. PubMed ID: 7522037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players.
    Hesry V; Piquet-Pellorce C; Travert M; Donaghy L; Jégou B; Patard JJ; Guillaudeux T
    Prostate; 2006 Jun; 66(9):987-95. PubMed ID: 16541419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer.
    Jenkins R; Takahashi S; DeLacey K; Bergstralh E; Lieber M
    Genes Chromosomes Cancer; 1998 Feb; 21(2):131-43. PubMed ID: 9491325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma.
    Ko JM; Chan PL; Yau WL; Chan HK; Chan KC; Yu ZY; Kwong FM; Miller LD; Liu ET; Yang LC; Lo PH; Stanbridge EJ; Tang JC; Srivastava G; Tsao SW; Law S; Lung ML
    Mol Cancer Res; 2008 Apr; 6(4):592-603. PubMed ID: 18403638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-induced decoy receptor 2 gene expression is regulated via a hypoxia-inducible factor 1alpha-mediated mechanism.
    Pei GT; Wu CW; Lin WW
    Biochem Biophys Res Commun; 2010 Jan; 391(2):1274-9. PubMed ID: 20018172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression mapping at 12p12-13 in advanced prostate carcinoma.
    Kibel AS; Huagen J; Guo C; Isaacs WB; Yan Y; Pienta KJ; Goodfellow PJ
    Int J Cancer; 2004 May; 109(5):668-72. PubMed ID: 14999772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.